Medicare-certified home health agencies will be required to implement the use of OASIS-E on January 1, 2023. An announcement by CMS last month stating the Office of Management and Budget (OMB) had approved the extension of OASIS-D until November 2024 was confusing to many of us. It seemed to directly contradict the Home Health Final…
Medicare-certified home health agencies will be required to implement the use of OASIS-E on January 1, 2023. An announcement by CMS last month stating the Office of Management and Budget (OMB) had approved the extension of OASIS-D until November 2024 was confusing to many of us. It seemed to directly contradict the Home Health Final Rule implementation of OASIS-E next year. Here’s the bottom line on that announcement: the OMB approves OASIS instruments for three year periods of time. Despite their approval of the current OASIS data set until 2024, agencies will begin using OASIS-E next year. With that clarification, please turn your attention to one of the new items, N0415, which will be collected at SOC/ROC and Discharge OASIS time points. This item specifically identifies the high-risk drug classes which require patient teaching: antipsychotics, anticoagulants, antibiotics, opioids, antiplatelets, and hypoglycemic drugs. Agencies would be wise to begin preparing their clinicians for this new item. Be watching for the release of the final version of OASIS-E within the next few months.
